S434-0650 Screening compound: N-cyclohexyl-6-methyl-4-(pyrrolidin-1-yl)pyrazolo[1,5-a]pyrazine-2-carboxamide

S434-0650 Screening compound: N-cyclohexyl-6-methyl-4-(pyrrolidin-1-yl)pyrazolo[1,5-a]pyrazine-2-carboxamide
S434-0650 Screening compound: N-cyclohexyl-6-methyl-4-(pyrrolidin-1-yl)pyrazolo[1,5-a]pyrazine-2-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound S434-0650
N-cyclohexyl-6-methyl-4-(pyrrolidin-1-yl)pyrazolo[1,5-a]pyrazine-2-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

S434-0650

Molecular Formula

C18H25N5O (C18 H25 N5 O)

Compound Name

N-cyclohexyl-6-methyl-4-(pyrrolidin-1-yl)pyrazolo[1,5-a]pyrazine-2-carboxamide

IUPAC name

N-cyclohexyl-6-methyl-4-(pyrrolidin-1-yl)pyrazolo[15-a]pyrazine-2-carboxamide

SMILES

Cc(nc(c1c2)N3CCCC3)cn1nc2C(NC1CCCCC1)=O

InChI

InChI=1S/C18H25N5O/c1-13-12-23-16(17(19-13)22-9-5-6-10-22)11-15(21-23)18(24)20-14-7-3-2-4-8-14/h11-12,14H,2-10H2,1H3,(H,20,24)

InChI Key

MWRQFNISGZFKSK-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD29005776

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

327.43

Hydrogen Bond Acceptors Count

4.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

4.00

Number of Nitrogen and Oxygen Atoms

6

Partition Coefficient, logP

3.128

Distribution Coefficient, logD

3.128

Water Solubility, LogSw

-3.19

Polar Surface Area

47.318

Acid Dissociation Constant (pKa)

14.48

Base Dissociation Constant (pKb)

4.13

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

61.10

S434-0650 in Drug Discovery

Included in Screening Libraries

3D-Diversity Natural-Product-Like Library (18102 compounds)

Bcl2-PPI Inhibitors Library (12246 compounds)

GPCR Targeted Library (31838 compounds)

Aurora A-B Kinases Targeted Library (9426 compounds)

Included in 1.7M Stock Database

Structure:
  • 3D
Therapeutical areas:
  • Cancer
  • Hemic and lymphatic
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
  • Cancer
  • Digestive system
  • Male
  • Female
  • Hemic and lymphatic
Mechanism of action:
  • PPI modulators
  • Receptor's ligands
Targets:
  • GPCR
  • Kinases

References: we are preparing a list of scientific research reports with S434-0650 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound S434-0650?
Check Price and Availability of S434-0650, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of S434-0650 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for S434-0650
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for S434-0650
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of S434-0650 available by request